01—Abstract
Summary
Summary of the 8-K filed June 9, 2025. Cited figures are marked; the original filing is the authoritative source.
International Flavors & Fragrances Inc. (IFF) disclosed in this Current Report on Form 8-K, dated June 9, 2025, that it has appointed Ms. Virginia Drosos to its board of directors, effective June 16, 2025.
Ms. Drosos is named to the Board's Audit Committee, Human Capital & Compensation Committee and Innovation Committee as of the effective date. The Board has determined she is independent under New York Stock Exchange rules and the Company's own independence requirements. Ms. Drosos, 62, previously served as Chief Executive Officer and director of Signet Jewelers Ltd. from August 2017 to November 2024, where the filing says she led a significant transformation that expanded digital capabilities and enhanced the customer experience.
Earlier, she was Chief Executive Officer of Assurex Health, Inc., where the filing says she delivered significant revenue growth and executed its strategic sale to Myriad Genetics, and she spent 25 years at Procter & Gamble. She currently serves as a director of Foot Locker Inc. and the United States Golf Association.
The filing states there is no arrangement or understanding under which she was appointed, and no related-person transaction exceeding $120,000a involving her since the beginning of IFF's last fiscal year. She will participate in the non-employee director compensation arrangements described in IFF's 2024 Proxy Statement, filed March 18, 2025.
02—Key points
Key Highlights
- Virginia Drosos appointed to IFF's board of directors, effective June 16, 2025
- Named to the Audit Committee, Human Capital & Compensation Committee and Innovation Committee as of the effective date
- Board determined Ms. Drosos is independent under NYSE rules and the Company's independence requirements
- Former Signet Jewelers CEO (August 2017 to November 2024) and former Assurex Health CEO, with 25 years at Procter & Gamble earlier in her career
- No related-person transactions above $120,000 and no appointment arrangement or understanding disclosed
- Will receive non-employee director compensation as described in IFF's 2024 Proxy Statement filed March 18, 2025
03—Questions
Frequently Asked Questions
When does Virginia Drosos's board appointment take effect?
Her appointment is effective June 16, 2025, as stated in the filing.
Which board committees will Ms. Drosos serve on?
The filing states she has been named to the Audit Committee, the Human Capital & Compensation Committee and the Innovation Committee as of the effective date.
Is Ms. Drosos considered independent?
Yes. The Board has determined she qualifies as an independent director under the applicable New York Stock Exchange rules and the Company's Board independence requirements.
What is Ms. Drosos's relevant background?
The filing says she served as Chief Executive Officer and director of Signet Jewelers Ltd. from August 2017 to November 2024, was previously CEO of Assurex Health, Inc., and spent 25 years at Procter & Gamble. She currently serves as a director of Foot Locker Inc. and the United States Golf Association.
How will Ms. Drosos be compensated as a director?
She will participate in the non-employee director compensation arrangements described in IFF's 2024 Proxy Statement, which was filed with the SEC on March 18, 2025.
04—Continue